FDA Device recall Z-2596-2018
EZ1 DSP Virus Kit (48), IVD, REF 62724 intended for in vitro diagnostic use
- FDA Device
- Class II
- terminated
- Published 2018-08-08
On 2018-08-08 the FDA classified a Class II recall of EZ1 DSP Virus Kit (48), IVD, REF 62724 intended for in vitro diagnostic use by Qiagen, citing underfilled reagent well that could lead to incorrect results.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2596-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-05-28 |
| Published | 2018-08-08 |
| Last updated | 2026-09-13 11:54 UTC |
| Company | Qiagen |
| Distribution | DE, MD |
Product
EZ1 DSP Virus Kit (48), IVD, REF 62724 intended for in vitro diagnostic use.
Reason
Underfilled reagent well that could lead to incorrect results
Identifiers
| code_info | UDI - 04053228000099 Lot - 160020069 Expiration - 11/01/19 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.
Other recalls by Qiagen
- therascreen ¿KRAS RGQ PCR Kit (24)-IVD qualitative PCR assay used on the Rotor-Gene Q MDx instrument for the detection of seven somatic mut…
FDA Device · Class II · 2023-10-11 · Qiagen - QIAstat-Dx¿ Respiratory SARS-CoV-2 Panel -IVD intended for the detection and differentiation of nucleic acid from SARS-CoV-2 and the follow…
FDA Device · Class II · 2023-08-02 · Qiagen - QIAstat-Dx Respiratory SARS-CoV-2 Panel -US IVD qualitative test intended for analyzing nasopharyngeal swab (NPS) samples from patients sus…
FDA Device · Class II · 2023-08-02 · Qiagen - QIAstat-Dx Respiratory SARS-CoV-2 Panel (V1 and V2, CE IVD, not US IVD, not sold in the US.) Qualitative test intended for analyzing nasoph…
FDA Device · Class II · 2023-08-02 · Qiagen - QIAamp DSP Virus Kit Cat
FDA Device · Class II · 2017-12-27 · Qiagen
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2596-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.